The rising convergence of biopharma, medtech and healthtech, which have traditionally been separate entities, is anticipated to modernize health care, drive innovation and improve health care. During the recent LSX World Congress USA in Boston, leaders from big pharma, biotech, venture capital, telemedicine, and consulting discussed opportunities and challenges in bringing together stakeholders to create change.
Digital Tech Convergence Is Transforming Health Care - LSX Panel
Leaders from Eli Lilly and Vertex Pharmaceuticals, 9amHealth, Features Capital, and accelerator PharmStars discussed the convergence of biopharma, medtech and healthtech, and what is needed to achieve health care transformation, in an LSX World Congress USA panel.
